In chronic myelogenous leukemia (CML) the tyrosine kinase ABL is often activated by a chromosomal translocation, t(9;22), resulting in fusion of BCR and ABL genes. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.